Quantum

Siloton Wins £8.4 Million Innovate UK Contract for Quantum Eye Imaging

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 14/10/2026, 12:20:27 UTC.

Briefings

Bristol-based Siloton secured a two-year Innovate UK contract worth £8.4 million to develop in-clinic and at-home versions of its GiraffeOCT retinal imaging system. The project involves clinical trials with Sunderland Specialist Eye Hospital and collaboration with York Health Economics Consortium to assess NHS cost savings. The funding is expected to accelerate product development by up to two years and support UK manufacturing plans, with the company targeting 16 employees by August 2028. CEO Alasdair Price stated the win helps accelerate development, explore UK assembly, and bring the technology closer to patients. The contract supports the NHS's National Quantum Strategy Missions to move care into communities. However, the specific impact on patient access and the exact timeline for the second-generation CheetahOCT device remain partially undefined.

Key points

• Siloton secured a £8.4 million two-year Innovate UK contract to develop in-clinic and at-home versions of its GiraffeOCT retinal imaging system.
• The project involves clinical trials with Sunderland Specialist Eye Hospital and collaboration with York Health Economics Consortium to assess NHS cost savings.

Context and limitations

Specific impact on patient access and the exact timeline for the second-generation CheetahOCT device remain partially undefined.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 14/10/2026, 20:34:31 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiawtoxk3hpdgmckiouwkra3yfyakjg5fvlhkfkduvfjpbssi233ve